EPHA3 and glioblastoma: Another Eph receptor, EphA3, is overexpressed in almost 60% of GBM patient samples [174] with increased presence in tumor initiating and infiltrating cells both in glioma [174] and leukemia [175], invasive rings, and scattered areas within the tumor and niches close to the blood vessels [174].